Drugs / 3804-250A
last change Dec 2009 re-read 3 minutes ago

3804-250A

Developed for
common cold
Investigated by
Hill Top Research · The Dial Corporation · TKL Research, Inc.

Trials 2

2009201020112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 2 NCT00993759 Aug → Nov 2009 common cold The Dial Corporation Unknown No outcome recorded
Phase 2 NCT00762476 Aug → Nov 2008 common cold The Dial Corporation Completed Missed primary

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 2 sources stand behind the page.

FieldValueCited text
Known as 3804-250A ClinicalTrials.gov intervention name — accepted as the source's own label NCT00993759 ↗
1

NCT00762476 ↗

Route Topical “* topical product” NCT00762476 ↗